3-Hydroxyvaleric acid

Common Name

3-Hydroxyvaleric acid Description

3-Hydroxyvaleric acid may be products of the condensation of propionyl-CoA with acetyl-CoA catalyzed by 3-oxoacyl-CoA thiolases. An increase amount of 3-hydroxyvaleric acid can be found in methylmalonic acidemia and propionic acidemia. (PMID: 630060 ). Structure

Synonyms

Value Source 3-Hydroxy-N-valerateHMDB 3-Hydroxy-N-valeric acidHMDB 3-Hydroxy-valerateHMDB 3-Hydroxy-valeric acidHMDB 3-HydroxypentanoateHMDB 3-Hydroxypentanoic acidHMDB 3-HydroxyvalerateHMDB b-Hydroxy-N-valerateHMDB b-Hydroxy-N-valeric acidHMDB b-HydroxyvalerateHMDB b-Hydroxyvaleric acidHMDB beta-Hydroxy-N-valerateHMDB beta-Hydroxy-N-valeric acidHMDB beta-HydroxyvalerateHMDB beta-Hydroxyvaleric acidHMDB

Chemical Formlia

C5H10O3 Average Molecliar Weight

118.1311 Monoisotopic Molecliar Weight

118.062994186 IUPAC Name

3-hydroxypentanoic acid Traditional Name

β-hydroxyvaleric acid CAS Registry Number

10237-77-1 SMILES

CCC(O)CC(O)=O

InChI Identifier

InChI=1S/C5H10O3/c1-2-4(6)3-5(7)8/h4,6H,2-3H2,1H3,(H,7,8)

InChI Key

REKYPYSUBKSCAT-UHFFFAOYSA-N Chemical Taxonomy Description

This compound belongs to the class of chemical entities known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group. Kingdom

Chemical entities Super Class

Organic compounds Class

Lipids and lipid-like moleclies Sub Class

Fatty Acyls Direct Parent

Hydroxy fatty acids Alternative Parents

  • Short-chain hydroxy acids and derivatives
  • Methyl-branched fatty acids
  • Beta hydroxy acids and derivatives
  • Secondary alcohols
  • Monocarboxylic acids and derivatives
  • Carboxylic acids
  • Organic oxides
  • Hydrocarbon derivatives
  • Carbonyl compounds
  • Substituents

  • Beta-hydroxy acid
  • Branched fatty acid
  • Hydroxy fatty acid
  • Short-chain hydroxy acid
  • Methyl-branched fatty acid
  • Hydroxy acid
  • Secondary alcohol
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Carboxylic acid derivative
  • Organooxygen compound
  • Alcohol
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organic oxygen compound
  • Aliphatic acyclic compound
  • Molecliar Framework

    Aliphatic acyclic compounds External Descriptors

  • Hydroxy fatty acids (LMFA01050008 )
  • Ontology Status

    Detected and Quantified Origin

  • Endogenous
  • Biofunction

    Not Available Application

    Not Available Cellliar locations

  • Cytoplasm
  • Physical Properties State

    Solid Experimental Properties

    Property Value Reference Melting PointNot AvailableNot Available Boiling PointNot AvailableNot Available Water SolubilityNot AvailableNot Available LogPNot AvailableNot Available

    Predicted Properties

    Property Value Source Water Solubility371.0 mg/mLALOGPS logP0.04ALOGPS logP0.14ChemAxon logS0.5ALOGPS pKa (Strongest Acidic)4.56ChemAxon pKa (Strongest Basic)-2.8ChemAxon Physiological Charge-1ChemAxon Hydrogen Acceptor Count3ChemAxon Hydrogen Donor Count2ChemAxon Polar Surface Area57.53 Å2ChemAxon Rotatable Bond Count3ChemAxon Refractivity27.99 m3·mol-1ChemAxon Polarizability11.95 Å3ChemAxon Number of Rings0ChemAxon Bioavailability1ChemAxon Rlie of FiveYesChemAxon Ghose FilterYesChemAxon Vebers RlieYesChemAxon MDDR-like RlieYesChemAxon

    Spectra Spectra

    Spectrum Type Description Splash Key Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available

    Biological Properties Cellliar Locations

  • Cytoplasm
  • Biofluid Locations

  • Blood
  • Cerebrospinal Fluid (CSF)
  • Feces
  • Urine
  • Tissue Location

    Not Available Pathways

    Not Available Normal Concentrations

    Biofluid Status Value Age Sex Condition Reference Details BloodDetected and Quantified1.0 (0.0-2.0) uMAdlit (>18 years old)Not SpecifiedNormal

  • 8074302
  • 4557757
  • details Cerebrospinal Fluid (CSF)Detected and Quantified1 (0-2) uMAdlit (>18 years old)Not SpecifiedNormal

  • 8074302
  • 4557757
  • details FecesDetected but not Quantified Infant (0-1 year old)Both

    Normal

  • 22411374
  • details UrineDetected and Quantified0.87-1.4 umol/mmol creatinineAdlit (>18 years old)FemaleNormal

  • 27012787
  • details UrineDetected and Quantified1 (0-2) umol/mmol creatinineAdlit (>18 years old)Not SpecifiedNormal

  • 8074302
  • 4557757
  • details UrineDetected and Quantified0.94-1.2 umol/mmol creatinineAdlit (>18 years old)MaleNormal

  • 27012787
  • details

    Abnormal Concentrations

    Not Available Associated Disorders and Diseases Disease References

    None Associated OMIM IDs

    None External Links DrugBank ID

    Not Available DrugBank Metabolite ID

    Not Available Phenol Explorer Compound ID

    Not Available Phenol Explorer Metabolite ID

    Not Available FoodDB ID

    FDB022099 KNApSAcK ID

    Not Available Chemspider ID

    96952 KEGG Compound ID

    Not Available BioCyc ID

    Not Available BiGG ID

    Not Available Wikipedia Link

    Not Available NuGOwiki Link

    HMDB00531 Metagene Link

    HMDB00531 METLIN ID

    5516 PubChem Compound

    107802 PDB ID

    Not Available ChEBI ID

    Not Available

    Product: 4,7-Dimethoxyisoflavone

    References Synthesis Reference Manufacture of b-hydroxyvaleric acid. Jpn. Kokai Tokkyo Koho (1982), 3 pp. Material Safety Data Sheet (MSDS) Not Available General References
    1. Kuhara T, Matsumoto I: Studies on the urinary acidic metabolites from three patients with methylmalonic aciduria. Biomed Mass Spectrom. 1980 Oct;7(10):424-8. [PubMed:6111361 ]
    2. Sweetman L, Weyler W, Nyhan WL, de Cespedes C, Loria AR, Estrada Y: Abnormal metabolites of isoleucine in a patient with propionyl-CoA carboxylase deficiency. Biomed Mass Spectrom. 1978 Mar;5(3):198-207. [PubMed:630060 ]
    3. Kuhara T, Inoue Y, Shinka T, Matsumoto I, Matsuo M: Identification of 3-hydroxy-3-ethylglutaric acid in urine of patients with propionic acidaemia. Biomed Mass Spectrom. 1983 Dec;10(12):629-32. [PubMed:6200156 ]
    4. Boger J, Payne LS, Perlow DS, Lohr NS, Poe M, Blaine EH, Ulm EH, Schorn TW, LaMont BI, Lin TY, et al.: Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine. J Med Chem. 1985 Dec;28(12):1779-90. [PubMed:3906131 ]
    5. Yuan L: [Propionic acidemia: one case report]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1991 Apr;13(2):141-3. [PubMed:1831712 ]

    PMID: 22057903